The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs
NCT05202275
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
43
Enrollment
OTHER
Sponsor class
Conditions
Nausea
Vomiting
Head and Neck Squamous Cell Carcinoma
Radiotherapy Side Effect
Interventions
DRUG:
Olanzapine
Sponsor
Chinese Academy of Medical Sciences